Sands Stephen H. 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Sands Stephen H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-22+28,300→ 28,300 totalExercise: $5.96Exp: 2032-02-22→ Common Stock (28,300 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of February 22, 2022, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.